The role of HMGB1 is being investigated in the context of possible novel treatments targeting the DAMP in several neurological conditions, such as stroke, subarachnoid hemorrhage, traumatic brain injury, epilepsy and neurodegenerative diseases [82]. Here, HMGB1 is linked to epilepsy.